调节性T细胞与乙型肝炎病毒感染的研究进展(4)
| 第1页 |
参见附件。
[14]Feng IC，Koay LB，Sheu MJ，et al. HBcAg-specific CD4+CD25+ regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection[J]. J Biomed Sci，2007，14(1)：43-57.
[15]Miyaaki H，Zhou H，Ichikawa T，et al. Study of liver-targeted regulatory T cells in hepatitis B and C virus in chronically infected patients[J]. Liver Int，2008，28(10)：1363-1369.
[16]Stoop JN，van der Molen RG，Baan CC，et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection[J]. Hepatology，2005，41(4)：771-778.
[17]Rehermann B，Lau D，Hoofnagle JH，et al. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection[J].J Clin Invest，1996，97(7)： 1655-1665.
[18]Maini MK，Boni C，Lee CK，et al. The Role of Virus-specific CD8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection[J]. J Exp Med，2000，191(8)： 1269-1280.
[19]Sprengers D，Stoop JN，Binda RS，et al. Induction of regulatory T-cells and interleukin-10-producing cells in non-responders to pegylated interferon-alpha therapy for chronic hepatitis B[J]. Antivir Ther，2007，12(7)：1087-1096.
[20]Stoop JN，van der Molen RG，Kuipers EJ，et al. Inhibition of viral replication reduces regulatory T cells and enhances the antiviral imm.
您现在查看是摘要介绍页，详见PDF附件。